| [1] |
Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2022 reportreport[R/OL]. [2021-11-20]. https://goldcopd.org/2022-gold-reports-2/.
|
| [2] |
Ritchie AI, Wedzicha JA. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clin Chest Med, 2020, 41(3):421-438. doi: 10.1016/j.ccm.2020.06.007.
doi: S0272-5231(20)30040-X
pmid: 32800196
|
| [3] |
Celli BR, Fabbri LM, Aaron SD, et al. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal. Am J Respir Crit Care Med, 2021, 204(11):1251-1258. doi: 10.1164/rccm.202108-1819PP.
doi: 10.1164/rccm.202108-1819PP
URL
|
| [4] |
Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987, 106(2):196-204. doi: 10.7326/0003-4819-106-2-196.
doi: 10.7326/0003-4819-106-2-196
pmid: 3492164
|
| [5] |
Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest, 2000, 117(5 Suppl 2):398S-401S. doi: 10.1378/chest.117.5_suppl_2.398s.
doi: 10.1378/chest.117.5_suppl_2.398s
URL
|
| [6] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版). 中华结核和呼吸杂志, 2021, 44(3):170-205. doi: 10.3760/cma.j.cn112147-20210109-00031.
doi: 10.3760/cma.j.cn112147-20210109-00031
|
| [7] |
Celli BR. Dissecting COPD exacerbations: time to rethink our definition. Eur Respir J, 2017, 50(3):1701432. doi: 10.1183/13993003.01432-2017.
doi: 10.1183/13993003.01432-2017
URL
|
| [8] |
Aaron SD, Donaldson GC, Whitmore GA, et al. Time course and pattern of COPD exacerbation onset. Thorax, 2012, 67(3):238-243. doi: 10.1136/thoraxjnl-2011-200768.
doi: 10.1136/thoraxjnl-2011-200768
URL
|
| [9] |
Lopez-Campos JL, Agustí A. Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal. Lancet Respir Med, 2015, 3(9):729-734. doi: 10.1016/S2213-2600(15)00242-8.
doi: 10.1016/S2213-2600(15)00242-8
URL
|
| [10] |
Wilson RC, Jones PW. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond), 1989, 76(3):277-282. doi: 10.1042/cs0760277.
doi: 10.1042/cs0760277
URL
|
| [11] |
Nikolakopoulou S, Hillas G, Perrea D, et al. Serum angiopoietin-2 and CRP levels during COPD exacerbations. Copd, 2014, 11(1):46-51. doi: 10.3109/15412555.2013.829436.
doi: 10.3109/15412555.2013.829436
pmid: 24102428
|
| [12] |
Carter JA, Burke HB. CRP-Guided Antibiotic Therapy for Acute COPD Exacerbation: a Randomized Control Trial. J Gen Intern Med, 2021, 36(7):2194-2196. doi: 10.1007/s11606-020-06053-0.
doi: 10.1007/s11606-020-06053-0
URL
|
| [13] |
Prins HJ, Duijkers R, van der Valk P, et al. CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions. Eur Respir J, 2019, 53(5):1802014. doi: 10.1183/13993003.02014-2018.
doi: 10.1183/13993003.02014-2018
URL
|
京公安网备11010202008787号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
